John Oliver DeLancey

Papers

Total Citations

H-Index

About

John Oliver DeLancey is a leading urologic oncologist whose research focuses on improving surgical outcomes for bladder cancer, particularly through the comparative analysis of open and robotic-assisted radical cystectomy. His most-cited work, a 2016 national comparison of oncologic quality indicators between these two approaches (29 citations), has been instrumental in shaping evidence-based guidelines for surgical decision-making. DeLancey’s contributions center on evaluating how minimally invasive techniques impact key metrics such as lymph node yield, margin status, and recurrence rates, directly influencing clinical practice in high-volume centers. Beyond this landmark study, his broader research portfolio examines patient-reported outcomes, cost-effectiveness, and the integration of novel technologies in urologic oncology. With a career dedicated to bridging surgical innovation and rigorous quality assessment, DeLancey’s work has helped define benchmarks for oncologic care, earning him recognition as a thought leader in the field. His findings continue to guide surgeons and trainees in balancing technical advances with proven oncologic principles, making his scholarship essential reading for those advancing bladder cancer treatment.